[
1. Zhang X, Zeng Q, Cai W, Ruan W. Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019. BMC Public Health. 2021;21(1):894. https://doi.org/10.1186/s12889-021-10907-5
]Search in Google Scholar
[
2. Green J, Kirwan J, Tierney J et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. The Lancet. 2001;358(9284):781-786. https://doi.org/10.1016/s0140-6736(01)05965-7
]Search in Google Scholar
[
3. Vinin N, Jones J, Ajas V et al. Organ at Risk Doses during High Dose Rate Intracavitary Brachytherapy for Cervical Cancer: A Dosimetric Study. International Journal of Medical Physics, Clinical Engineering and Radiation Oncology. 2018;07(04):472-478. https://doi.org/10.4236/ijmpcero.2018.78040
]Search in Google Scholar
[
4. Pötter R, Haie-Meder C, Van Limbergen E et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiotherapy and Oncology. 2006;78(1):67-77. https://doi.org/10.1016/j.radonc.2005.11.014
]Search in Google Scholar
[
5. Nag S, Erickson B, Thomadsen B et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. International Journal of Radiation Oncology*Biology*Physics. 2000;48(1):201-211. https://doi.org/10.1016/s0360-3016(00)00497-1
]Search in Google Scholar
[
6. Swamidas J, Mahantshetty U. ICRU report 89: prescribing, recording, and reporting brachytherapy for cancer of the cervix. Journal of Medical Physics. 2017;42(suppl1);48.
]Search in Google Scholar
[
7. Romano K, Hill C, Trifiletti D et al. High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events. Radiation Oncology. 2018;13(1). https://doi.org/10.1186/s13014-018-1074-2604883830012164
]Search in Google Scholar
[
8. Tornero-López A, Guirado D. Radiobiological considerations in combining doses from external beam radiotherapy and brachytherapy for cervical cancer. Reports of Practical Oncology & Radiotherapy. 2018;23(6):562-573. https://doi.org/10.1016/j.rpor.2018.05.007627727230534020
]Search in Google Scholar
[
9. Wang C, Huang E, Sun L et al. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer. International Journal of Radiation Oncology*Biology*Physics. 2004;59(1):179-189. https://doi.org/10.1016/j.ijrobp.2003.10.02515093915
]Search in Google Scholar
[
10. Vinin N, Dharmarajan A, Sahin PM et al. Dosimetric comparison of tandem and ovoids with tandem and ring for intracavitary brachytherapy for carcinoma cervix. Oncology and Radiotherapy. 2019;46(1):39-42.
]Search in Google Scholar
[
11. Rangarajan R. Dosimetric evaluation of image based brachytherapy using tandem ovoid and tandem ring applicators. Reports of Practical Oncology & Radiotherapy. 2018;23(1):57-60. https://doi.org/10.1016/j.rpor.2017.12.006576784429348735
]Search in Google Scholar
[
12. Levin D, Menhel J, Rabin T, Pfeffer M, Symon Z. Dosimetric Comparison of Tandem and Ovoids vs. Tandem and Ring for Intracavitary Gynecologic Applications. Medical Dosimetry. 2008;33(4):315-320. https://doi.org/10.1016/j.meddos.2008.06.00318973861
]Search in Google Scholar
[
13. Erickson B, Jones R, Rownd J et al. Is the tandem and ring applicator a suitable alternative to the high dose rate selectron tandem and ovoid applicator? Journal of Brachytherapy International. 2000;16(2):131-144.
]Search in Google Scholar
[
14. Harmon G, Diak A, Shea S, Yacoub J, Small W, Harkenrider M. Point A vs. HR-CTV D90 in MRI-based cervical brachytherapy of small and large lesions. Brachytherapy. 2016;15(6):825-831. https://doi.org/10.1016/j.brachy.2016.08.010
]Search in Google Scholar
[
15. Dumane V, Yuan Y, Sheu R, Gupta V. Computed tomography-based treatment planning for high-dose-rate brachytherapy using the tandem and ring applicator: influence of applicator choice on organ dose and inter-fraction adaptive planning. J Contemp Brachytherapy. 2017;3:279-286. https://doi.org/10.5114/jcb.2017.68519
]Search in Google Scholar
[
16. Noyes W, Peters N, Thomadsen B et al. Impact of “optimized” treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer. International Journal of Radiation Oncology*Biology*Physics. 1995;31(1):79-86. https://doi.org/10.1016/0360-3016(94)00401-6
]Search in Google Scholar
[
17. Siavashpour Z, Aghamiri M, Jaberi R et al. A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes. J Appl Clin Med Phys. 2016;17(3):5-13. https://doi.org/10.1120/jacmp.v17i3.5584569092727167253
]Search in Google Scholar
[
18. Suryadevara A, Kumar M, Vasundhara E, Alluri K, Ahamed S, Guduru S. A dosimetric comparison between applicators used for brachytherapy in carcinoma cervix – A single-institute prospective study. Indian J Cancer. 2018;55(3):230. https://doi.org/10.4103/ijc.ijc_659_17
]Search in Google Scholar
